Source bp usp ketoprofen injection for pain relief, fever, and inflammation

Strategic Sourcing Guide for BP USP Ketoprofen Injection

The procurement of pharmaceutical ingredients and finished dosage forms, specifically targeting Ketoprofen Injection under BP (British Pharmacopoeia) and USP (United States Pharmacopeia) standards, requires a rigorous, evidence-based approach. Buyers in the B2B sector must navigate a complex landscape where product attributes, regulatory compliance, and supply chain reliability intersect. The following guide synthesizes observed market data and technical specifications to provide a framework for sourcing high-quality Ketoprofen Injection. This analysis focuses on the critical dimensions of specification verification, certification validation, cost structure, and long-term supplier partnership, ensuring that procurement decisions are grounded in verified facts rather than unconfirmed claims.

Technical Specifications and Dosage Form Analysis

When sourcing Ketoprofen Injection, the primary technical differentiator lies in the physical state and packaging configuration of the product. Market observations indicate a divergence in product forms, ranging from solid powders to liquid injections, which necessitates precise specification matching. The core keyword "Ketoprofen Injection" implies a liquid state, yet the available data includes attributes for "Powder" and "Oral Liquid" forms. A buyer must verify that the specific lot or batch corresponds to the "Liquid" state and "Injection" product type, distinct from solid or oral formulations.

The standard specifications observed in the market include varying volumes and container types. Critical technical parameters include the "100ml/bottle" standard and the "10ml amber tubular vial" configuration. The use of amber glass is a specific technical requirement for light-sensitive compounds, aligning with the "Light Proof" storage method observed in the product attributes. Furthermore, the pH range is a vital quality indicator, with observed data suggesting a stability window of 5.2 to 6.5. Buyers must ensure that the technical data sheet (TDS) provided by the supplier explicitly confirms this pH range to guarantee chemical stability and patient safety.

Packaging is another critical technical variable. The market displays a wide array of packaging configurations, including "1vials/Box," "10vials/Tray/Box," and bulk options like "600/1000vial/Carton." The "Carton" and "Box" are standard outer packaging materials, but the internal arrangement—whether trays or direct box packing—impacts logistics and breakage rates. Additionally, the "10AMPS/Tray/Box" specification highlights the use of ampoules as a specific container type for liquid injections. Procurement teams must align their internal logistics capabilities with the specific packaging format, as the transition from small vials to large cartons affects handling procedures and storage requirements.

Regulatory Compliance and Certification Verification

In the pharmaceutical sector, regulatory compliance is not merely a formality but a prerequisite for market entry and patient safety. The sourcing of Ketoprofen Injection requires strict adherence to international pharmacopoeial standards. The observed data explicitly references "BP USP" and "Cp, Bp, USP" as the governing standards. These acronyms denote compliance with the British Pharmacopoeia and the United States Pharmacopeia, which are the gold standards for drug quality in many global markets. Buyers must verify that the supplier's documentation certifies the product meets these specific monographs, rather than relying on generic "Medicine Grade" claims.

Certification status is a primary filter for supplier evaluation. The data indicates that suppliers may hold "GMP" (Good Manufacturing Practice), "SGS," and "ISO" certifications. While "GMP" is listed as a standalone certification and also part of a combined list, its presence is essential for any facility manufacturing injectable products. The "SGS" certification implies third-party verification of quality and safety, adding a layer of external validation. However, buyers must be cautious not to assume that every listed product satisfies all certifications simultaneously. The presence of "GMP" and "ISO" in the attribute list suggests a high level of regulatory maturity, but verification of the specific certificate validity and scope is mandatory.

Furthermore, the "Sterile" attribute is a critical compliance factor for injections. The data confirms a "Yes" status for sterility, but this must be corroborated by batch-specific test reports. The "Light Proof" storage requirement is also a regulatory implication, as improper storage can degrade the active ingredient, rendering the product non-compliant with BP/USP standards. Buyers should request evidence of the storage conditions maintained during transit to ensure the "Light Proof" integrity is preserved from the point of manufacture to the point of delivery.

Cost Drivers and Pricing Dynamics

The pricing structure for Ketoprofen Injection is influenced by a complex interplay of factors, including volume, packaging, and certification levels. The observed price range in the market spans from 0 to 6.4 USD, a broad spectrum that likely reflects differences in unit size, packaging configuration, and order volume. The lower end of this range may correspond to bulk raw materials or smaller unit sizes, while the higher end could reflect finished, sterile, and certified injection products.

The Minimum Order Quantity (MOQ) is a significant cost driver, with observed ranges extending from 10 to 1,000,000 units. This vast range indicates that the market accommodates both small-scale procurement for clinical trials or pilot programs and large-scale distribution for national supply chains. Buyers must align their financial planning with the MOQ structure of their chosen supplier. Ordering at the lower end of the MOQ range (e.g., 10 units) may result in a higher unit cost due to fixed production and packaging overheads, whereas ordering near the upper limit (e.g., 1,000,000 units) typically yields significant economies of scale.

Additionally, the "Grade Standard" of "Medicine Grade" suggests that the cost includes the premium associated with pharmaceutical-grade purity. The "Chemical Synthetic Drugs" classification implies that the manufacturing process involves complex synthesis, which can influence the base cost. Buyers should analyze the cost per unit in the context of the packaging format; for instance, the "100ml/bottle" format may have a different cost structure compared to the "10ml amber tubular vial." Understanding these variables is essential for accurate budgeting and negotiating favorable terms with suppliers.

Typical Applications and Therapeutic Scope

Ketoprofen Injection is primarily indicated for its therapeutic efficacy in managing pain and inflammation. The observed attributes describe the product as having "Antibacterial" efficacy, though this is less common for non-steroidal anti-inflammatory drugs (NSAIDs) and may refer to specific formulations or a misclassification in the general data. More accurately, the product is defined by its "Antipyretic Analgesic and Non-Steroidal Anti-Inflammatory Analgesic" function. This classification places the drug in the category of agents used to reduce fever, alleviate pain, and decrease inflammation.

The application scope is broad, covering "Internal Medicine" and "General Disease Prevention Medicine." The product is suitable for a wide demographic, including "Adult, Children, Elderly," which necessitates careful dosage adjustments and safety monitoring. The "Parasite Disease Prevention Medicine" attribute observed in the data suggests a potential dual-use or a specific formulation for veterinary applications, as Ketoprofen is also used in animal health. Buyers must clarify the intended market—human or veterinary—as this distinction impacts regulatory requirements and labeling.

The "Pharmacodynamic Influential Factors" note "Animal Species," further reinforcing the potential for veterinary use. In human medicine, the "Application" is strictly "Internal Medicine," typically administered via injection for rapid onset of action in acute pain or post-operative settings. The "Usage Mode" being "For external use" in some data points presents a contradiction to the "Injection" type, highlighting the necessity for buyers to verify the specific usage instructions for the batch they intend to procure. Ensuring the product matches the intended therapeutic application is crucial to avoid regulatory violations and ensure patient safety.

Supplier Evaluation and Quality Control Protocols

Evaluating suppliers for Ketoprofen Injection requires a multi-faceted approach that goes beyond price and availability. The "prod_origin" data points to "Shijiazhuang, Hebei, China" and "China Reyoung," indicating that the supply chain is heavily concentrated in specific regions of China. While this provides a clear geographical focus, buyers must conduct due diligence on the specific manufacturing facilities within these locations. The presence of "GMP" certification is a baseline requirement, but buyers should also verify the facility's inspection history and compliance record with local and international health authorities.

Quality control (QC) is paramount in the procurement of injectable products. The "Sterile" attribute and "Light Proof" storage requirement are non-negotiable quality markers. Buyers should request detailed QC reports for each batch, including sterility testing results, endotoxin levels, and potency assays. The "Standard" of "0.6mega 1.2mega 2.4mega" observed in the data is ambiguous and may refer to specific potency levels or particle counts, requiring clarification from the supplier. Similarly, the "Indate" of "3years" defines the shelf life, but buyers must verify the stability data supporting this claim.

The "prod_packing" variations, such as "1 Bottle/Box; 10bottles/Tray" or "10vials/Tray/Box," also serve as a proxy for quality control. Consistent packaging indicates a mature manufacturing process, while erratic packaging may suggest a lack of standardization. Buyers should assess the supplier's ability to maintain the integrity of the "Carton" and "Box" packaging during transit, especially for light-sensitive products. The "Chemical Synthesis" process implies a need for rigorous control over impurities and by-products, which should be documented in the Certificate of Analysis (CoA).

Long-Term Procurement Considerations and Supply Chain Resilience

Sourcing Ketoprofen Injection is not a one-time transaction but a strategic partnership that requires long-term planning. The "MOQ range" of 10 to 1,000,000 units suggests that suppliers are capable of scaling production, but buyers must assess the supplier's capacity to handle sudden demand spikes or supply chain disruptions. The "Lead time" is not explicitly provided in the data, but it is a critical factor for inventory management. Buyers should negotiate clear lead time commitments and establish contingency plans for potential delays.

The "Certificate" status, including "GMP, SGS, ISO," should be monitored for renewal and validity. Regulatory landscapes change frequently, and a supplier's certification status can impact the marketability of the product. Buyers should maintain a proactive relationship with suppliers to stay informed about any regulatory updates or changes in pharmacopoeial standards. The "Storage Method" of "Light Proof" also requires a robust logistics network to ensure that the product remains protected throughout the supply chain.

Finally, the "Type" classification of "The First Class" and "Biological Products" (though potentially conflicting with "Chemical Synthetic Drugs") highlights the need for precise categorization. Buyers must ensure that the product classification aligns with their internal inventory systems and regulatory reporting requirements. Long-term success in sourcing Ketoprofen Injection depends on a supplier's ability to maintain consistent quality, adhere to strict standards, and provide transparent communication. By focusing on these strategic elements, buyers can build a resilient supply chain that ensures the availability of high-quality Ketoprofen Injection for their specific market needs.

Comparative Analysis of Product Attributes

To facilitate decision-making, the following table summarizes the key product attributes observed in the market for Ketoprofen Injection. This comparison helps buyers distinguish between different product offerings and identify the specifications that align with their requirements.

This table serves as a quick reference for buyers to cross-check supplier data against their procurement criteria. It highlights the importance of verifying specific attributes rather than accepting general market descriptions. By systematically evaluating these factors, buyers can mitigate risks and ensure the acquisition of Ketoprofen Injection that meets the highest standards of quality and safety.